[go: up one dir, main page]

AR066584A1 - Formulaciones farmaceuticas que contienen nicotina. uso. - Google Patents

Formulaciones farmaceuticas que contienen nicotina. uso.

Info

Publication number
AR066584A1
AR066584A1 ARP080102064A ARP080102064A AR066584A1 AR 066584 A1 AR066584 A1 AR 066584A1 AR P080102064 A ARP080102064 A AR P080102064A AR P080102064 A ARP080102064 A AR P080102064A AR 066584 A1 AR066584 A1 AR 066584A1
Authority
AR
Argentina
Prior art keywords
nicotine
oral
oral formulation
amino acid
tablet
Prior art date
Application number
ARP080102064A
Other languages
English (en)
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of AR066584A1 publication Critical patent/AR066584A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/44—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/14—Chewing gum characterised by the composition containing organic or inorganic compounds containing peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Physiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Mycology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una formulacion farmacéutica oral para proveer nicotina en cualquier forma a un sujeto por captacion transmucosa en la cavidad oral que comprende nicotina en cualquier forma, en donde dicha formulacion oral tiene un buffer de al menos un aminoácido,de preferencia al menos un aminoácido endogeno. También se contempla un método para la provision oral de nicotina en cualquier forma, un método para la reduccion de la urgencia de fumar o el uso de tabaco así como métodos para fabricar laformulacion oral, el uso de dicha formulacion oral para obtener captacion transmucosa de nicotina en la cavidad oral de un sujeto, y el uso de nicotina para la produccion de una formulacion oral para el tratamiento de una enfermedad seleccionado delgrupo que consiste en dependencia de tabaco o nicotina, enfermedad de Alzheimer, enfermedad de Crohn enfermedad de Parkinson, síndrome de Tourette, colitis ulcerosa y control de peso posterior al cese del hábito de fumar. Reivindicacion 3: Laformulacion oral de acuerdo con la reivindicacion 2, caracterizada porque el al menos un aminoácido en1ogeno se elige de arginina, asparagina, ácido glutámico, glutamina, glicina, histidina, isoleucina, leucina, lisina, metionina, ornitina,fenilalanina, serina, treonina y valina. Reivindicacion 5: La formulacion oral de acuerdo con la reivindicacion 1, caracterizada porque el al menos un aminoácido se elige de ácido cisteico, N-glicilglicina y ornitina. Reivindicacion 9: Laformulacion oral de acuerdo con cualquiera de las reivindicaciones 1-8, en donde la nicotina en cualquier forma se selecciona del grupo que consiste en una sal de nicotina, la forma de base libre de nicotina, un derivado de nicotina, tal como unintercambiador cationico de nicotina, un complejo de inclusion de nicotina o nicotina en cualquier union no covalente; nicotina unido a zeolitas; nicotina unido a celulosa o microesferas de almidon; y sus mezclas. Reivindicacion 17: La formulacionoral de acuerdo con cualquiera de las reivindicaciones 1-16 en la forma de rocío bucal, cápsula, goma de mascar, comprimido masticable, comprimido, comprimido fundido, pastilla, caramelo duro fundido, caramelo masticable, goma, o película oral.
ARP080102064A 2007-05-16 2008-05-15 Formulaciones farmaceuticas que contienen nicotina. uso. AR066584A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0701178 2007-05-16
US11/803,747 US20080286340A1 (en) 2007-05-16 2007-05-16 Buffered nicotine containing products

Publications (1)

Publication Number Publication Date
AR066584A1 true AR066584A1 (es) 2009-09-02

Family

ID=40002443

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102064A AR066584A1 (es) 2007-05-16 2008-05-15 Formulaciones farmaceuticas que contienen nicotina. uso.

Country Status (14)

Country Link
US (1) US20080286340A1 (es)
EP (1) EP2152313B1 (es)
JP (1) JP2010526875A (es)
KR (1) KR20100017820A (es)
CN (1) CN101795710A (es)
AR (1) AR066584A1 (es)
AU (1) AU2008251095B2 (es)
BR (1) BRPI0811110A2 (es)
CA (1) CA2685452A1 (es)
MX (1) MX2009012485A (es)
NZ (1) NZ580732A (es)
RU (1) RU2465904C2 (es)
WO (1) WO2008140371A1 (es)
ZA (1) ZA200908960B (es)

Families Citing this family (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60313216T2 (de) 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
MXPA06000852A (es) * 2003-07-24 2006-03-30 Smithkline Beecham Corp Peliculas que se disuelven oralmente.
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
EP1998748B1 (en) 2006-03-16 2015-01-14 NicoNovum AB Improved snuff composition
JP2010538669A (ja) * 2007-09-18 2010-12-16 ニコノヴァム エービー ニコチンの迅速な放出をもたらす、マルチトールを含有する安定なチューイングガム組成物
BRPI0819231B8 (pt) * 2007-10-31 2021-05-25 Mcneil Ppc Inc processo para preparo de forma farmacêutica de desintegração rápida por moldagem a quente na presença de sal inorgânico hidratado
WO2009079078A1 (en) 2007-12-14 2009-06-25 Labogroup S.A.S. Delivering aerosolizable food products
US8991402B2 (en) 2007-12-18 2015-03-31 Pax Labs, Inc. Aerosol devices and methods for inhaling a substance and uses thereof
AR071420A1 (es) 2008-05-01 2010-06-16 Smithkline Beecham Corp Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla
CA2736531C (en) * 2008-09-17 2016-10-25 Niconovum Ab Process for preparing snuff composition
JP2012517402A (ja) * 2009-02-11 2012-08-02 ヘグルンド、エー．エス． 禁煙を目的としたニコチンを頬側吸収するための組成物
US20100226904A1 (en) * 2009-03-05 2010-09-09 Hero Nutritionals, LLC Organic chewable supplement
US20110070301A1 (en) * 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US8313768B2 (en) * 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
JP6306349B2 (ja) 2010-04-14 2018-04-04 アルトリア クライアント サービシーズ リミテッド ライアビリティ カンパニー 予成形無煙タバコ製品
WO2011134846A1 (en) * 2010-04-27 2011-11-03 Novartis Ag Oral dosage forms
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CA2794420A1 (en) * 2010-05-13 2011-12-01 Astrazeneca Ab Injectable emulsion of sedative hypnotic agent
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CN102511921B (zh) * 2011-12-30 2014-02-26 华宝食用香精香料（上海）有限公司 一种膜状口含烟的制备方法
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US10799451B2 (en) * 2012-03-27 2020-10-13 Nicoccino Ab Nicotine formulation
WO2013143891A1 (en) * 2012-03-27 2013-10-03 Uppsalagruppen Medical Ab Nicotine formulation
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US10517530B2 (en) 2012-08-28 2019-12-31 Juul Labs, Inc. Methods and devices for delivering and monitoring of tobacco, nicotine, or other substances
CN103099308A (zh) * 2012-11-13 2013-05-15 苏州谷力生物科技有限公司 一种改性糊精烟用保润剂的制备方法
EP2919767B1 (en) * 2012-11-14 2020-04-01 Abon Pharmaceuticals, LLC Oral transmucosal drug delivery system
CA2905099A1 (en) * 2013-03-14 2014-10-02 Altria Client Services Llc Soft oral product
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
US10130120B2 (en) 2013-03-15 2018-11-20 Altria Client Services Llc Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
FR3005262A1 (fr) * 2013-05-02 2014-11-07 Philippe Gorny Nouvelles compositions pharmaceutiques ou dietetiques permettant de masquer totalement l'amertume des sels d'arginine donnes a haute dose, sous forme liquide ou semi-liquide.
MX384606B (es) 2013-05-06 2025-03-12 Juul Labs Inc Formulaciones de sal de nicotina para dispositivos de aerosol y métodos de los mismos.
CN111642812A (zh) 2013-06-14 2020-09-11 尤尔实验室有限公司 电子汽化设备中的具有单独的可汽化材料的多个加热元件
US10463069B2 (en) 2013-12-05 2019-11-05 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
JP6653432B2 (ja) 2013-12-23 2020-02-26 ジュール・ラブズ・インコーポレイテッドＪｕｕｌ Ｌａｂｓ， Ｉｎｃ． 気化装置のシステムおよび方法
AU2015204763A1 (en) 2014-01-10 2016-07-21 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CN103734904B (zh) * 2014-01-21 2016-01-20 江苏中烟工业有限责任公司 一种滋阴降火型烟草口腔喷剂及其制备方法
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
CN103815542B (zh) * 2014-02-21 2016-09-21 湖北中烟工业有限责任公司 四层烟用水胶囊及其制备方法
EP3129024A4 (en) * 2014-04-08 2017-11-22 Sansa Corporation (Barbados) Inc. Nicotine formulations and methods of making the same
US11478021B2 (en) 2014-05-16 2022-10-25 Juul Labs, Inc. Systems and methods for aerosolizing a vaporizable material
CN103948164B (zh) * 2014-05-19 2016-08-24 川渝中烟工业有限责任公司 口含烟提取液及其制备方法和口含烟
CN104082851A (zh) * 2014-07-08 2014-10-08 山东津美生物科技有限公司 烟草粘合剂及其制备方法与应用
CN104068465B (zh) * 2014-07-08 2016-02-03 川渝中烟工业有限责任公司 浓香型口含烟的制备方法
JP6419208B2 (ja) * 2014-10-24 2018-11-07 日本たばこ産業株式会社 口腔用たばこ組成物及びその製造方法
KR102574658B1 (ko) 2014-12-05 2023-09-05 쥴 랩스, 인크. 교정된 투여량 제어
JP6324349B2 (ja) * 2015-06-26 2018-05-16 長谷川香料株式会社 塩味増強剤
GB201511284D0 (en) * 2015-06-26 2015-08-12 Univ Witwatersrand Jhb An oral pharmaceutical dosage form for the delivery of a peptide and/or protein
CN104970445B (zh) * 2015-07-21 2017-11-07 中国烟草总公司广东省公司 一种缓释型气雾口香烟
US11224594B2 (en) * 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
CN105230940B (zh) * 2015-10-20 2021-06-22 贵州中烟工业有限责任公司 一种功能性硬质糖果及其制备方法
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
WO2017139595A1 (en) 2016-02-11 2017-08-17 Pax Labs, Inc. Fillable vaporizer cartridge and method of filling
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
WO2017182084A1 (en) 2016-04-21 2017-10-26 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
WO2018002779A1 (en) 2016-06-30 2018-01-04 Philip Morris Products S.A. Nicotine particles
US20190133940A1 (en) * 2016-06-30 2019-05-09 Philip Morris Products S.A. Nicotine particles and compositions
US11660403B2 (en) 2016-09-22 2023-05-30 Juul Labs, Inc. Leak-resistant vaporizer device
US20180103681A1 (en) * 2016-10-18 2018-04-19 Altria Client Services Llc Methods and systems for increasing stability of the pre-vapor formulation of an e-vaping device
US20180263904A1 (en) 2017-03-20 2018-09-20 Bayer Healthcare Llc Chewable gel products for active pharmaceutical ingredients
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
US10500155B2 (en) 2017-05-22 2019-12-10 Johnson & Johnson Consumer Inc. Lozenge dosage form having a disintegrative tablet portion and a candy glass shell portion
US20200315241A1 (en) * 2017-06-26 2020-10-08 Nude Nicotine, Inc. Nicotine Salts and Methods of Making and Using Same
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
GB2569940B (en) * 2017-11-01 2022-10-19 Nicoventures Trading Ltd Aerosolisable formulation
US20190174812A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
US20200397691A1 (en) * 2017-12-08 2020-12-24 Fertin Pharma A/S Nicotine mouth spray
PL3720418T3 (pl) 2017-12-08 2021-12-20 Fertin Pharma A/S Tabletka nikotynowa
WO2019110075A1 (en) 2017-12-08 2019-06-13 Fertin Pharma A/S High nicotine concentration
US12048322B2 (en) 2017-12-29 2024-07-30 Philip Morris Products S.A. Method for the preparation of a material containing alkaloids and aerosol forming article comprising a component prepared from it
US20190246686A1 (en) * 2018-02-15 2019-08-15 Altria Client Services Llc Alternative Nicotine Carriers for Solid Products
US12285488B2 (en) 2018-03-01 2025-04-29 Lts Lohmann Therapie-Systeme Ag Oral dosage form containing theobromine-free cocoa
US20210255202A1 (en) 2018-06-13 2021-08-19 Michael R. D'Andrea Methods and dosing regimens for preventing or delaying onset of alzheimer's disease and other forms of dementia and mild congnitive impairment
GB201817865D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817860D0 (en) 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolised formulation
SE544446C2 (en) * 2019-02-01 2022-05-31 Swedish Match North Europe Ab AN ORAL NICOTINE PRODUCT COMPRISING A pH ADJUSTING AGENT
CN110384700A (zh) * 2019-09-03 2019-10-29 云南喜科科技有限公司 一种合成尼古丁的组合物
JP2023504756A (ja) 2019-12-09 2023-02-06 ニコベンチャーズ トレーディング リミテッド カンナビノイドを含む口腔用製品
US11541004B2 (en) * 2020-06-10 2023-01-03 Howard University Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
US11911375B2 (en) * 2020-11-16 2024-02-27 Fertin Pharma A/S Solid oral nicotine formulation
CN112841709B (zh) * 2021-01-20 2022-11-25 深圳市艾普生物科技有限公司 一种尼古丁盐的制备方法及应用
DE102021105268A1 (de) 2021-03-04 2022-09-08 Lts Lohmann Therapie-Systeme Ag. Oraler Dünnfilm
EP4304569A1 (en) * 2021-03-12 2024-01-17 Nicoventures Trading Limited Oral products with self-emulsifying system
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
EP4326097A1 (en) * 2021-04-22 2024-02-28 Nicoventures Trading Limited Oral compositions and methods of manufacture
CA3231103A1 (en) 2021-10-08 2023-04-13 Venda Porter MALONEY Oral compositions comprising arginine and gelling agent
CN113880802A (zh) * 2021-11-09 2022-01-04 深圳萨特瓦生物科技有限公司 酒石酸-尼古丁盐及其制备方法与应用、无水酒石酸晶体的制备方法
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product
KR102780723B1 (ko) * 2022-02-09 2025-03-12 주식회사 케이티앤지 반고체 매질부를 포함하는 비가열식 흡연물품
EP4585058A1 (en) 2022-09-07 2025-07-16 Japan Tobacco Inc. Oral pouch product containing amino acid or salt thereof
EP4410123A1 (en) * 2023-02-03 2024-08-07 Contraf-Nicotex-Tobacco GmbH Oral product for delivery of an active ingredient
CN115989891A (zh) * 2023-02-09 2023-04-21 东莞市吉纯生物技术有限公司 一种尼古丁盐口含制品及其制备方法
WO2024037043A1 (zh) * 2023-04-28 2024-02-22 深圳华宝协同创新技术研究院有限公司 用于口腔粘膜的包含尼古丁的薄膜组合物

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
JPS55122709A (en) * 1979-03-13 1980-09-20 Asama Kasei Kk Stench remover from mouth
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5009893A (en) * 1989-07-17 1991-04-23 Warner-Lambert Company Breath-freshening edible compositions of methol and a carboxamide
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5165943A (en) * 1991-06-21 1992-11-24 Wm. Wrigley Jr. Company Cooling agent/cyclodextrin complex for improved flavor release
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5652216A (en) * 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US5578563A (en) * 1994-08-12 1996-11-26 The Procter & Gamble Company Composition for reducing malodor impression on inanimate surfaces
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5810018A (en) * 1994-12-29 1998-09-22 Monte; Woodrow C. Method, composition and apparatus for reducing the incidence of cigarette smoking
NL1002833C2 (nl) * 1996-04-10 1997-04-03 Gerardus Joannes Emile Maria N Werkwijze, voor duurzame ontwenning van/aan nicotine en andere verslavende producten door toediening van sex steroide voorlopers (precursors), alsmede het gebruik van die voorlopers als medicijn.
EP0803243B1 (en) * 1996-04-24 2003-03-19 Pfizer Inc. Cyclodextrins and phenolic compounds in dental products
US5866179A (en) * 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
WO1997042941A2 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Buccal delivery system
US5885599A (en) * 1996-10-28 1999-03-23 The Procter & Gamble Company Methods and compositions for reducing body odors and excess moisture
US5780020A (en) * 1996-10-28 1998-07-14 The Proctor & Gamble Company Methods and compositions for reducing body odor
US5942214A (en) * 1997-06-09 1999-08-24 The Procter & Gamble Company Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins and perfume
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6197288B1 (en) * 1997-10-16 2001-03-06 Bush Boake Allen, Inc. Malodor counteractant compositions and method for preparing and using same
ES2205934T3 (es) * 1998-11-25 2004-05-01 THE PROCTER & GAMBLE COMPANY Composiciones mejoradas de ciclodextrina sin complejar para el control del olor.
US6680289B1 (en) * 1999-09-02 2004-01-20 The Proctor & Gamble Company Methods, compositions, and articles for odor control
US6497859B1 (en) * 2000-11-17 2002-12-24 Noville Inc. Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
DE60105820D1 (de) * 2001-10-22 2004-10-28 Pera Ivo E Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040101543A1 (en) * 2002-03-22 2004-05-27 John Liu Nicotine-containing oral dosage form
US20040018157A1 (en) * 2002-07-25 2004-01-29 Masters James G. Oral composition providing enhanced oral hygiene properties
US20040180110A1 (en) * 2003-03-14 2004-09-16 Atul Mistry Chewing gum and confectionery compositions containing an endothermic agent
JP4604034B2 (ja) * 2003-09-08 2010-12-22 マクニール・アクチェボラーグ ニコチン製剤およびその使用

Also Published As

Publication number Publication date
CA2685452A1 (en) 2008-11-20
JP2010526875A (ja) 2010-08-05
ZA200908960B (en) 2011-02-23
WO2008140371A1 (en) 2008-11-20
US20080286340A1 (en) 2008-11-20
NZ580732A (en) 2012-05-25
EP2152313A1 (en) 2010-02-17
EP2152313B1 (en) 2014-09-03
EP2152313A4 (en) 2013-08-07
CN101795710A (zh) 2010-08-04
RU2009146576A (ru) 2011-06-27
BRPI0811110A2 (pt) 2014-12-09
KR20100017820A (ko) 2010-02-16
MX2009012485A (es) 2009-12-02
AU2008251095A1 (en) 2008-11-20
RU2465904C2 (ru) 2012-11-10
AU2008251095B2 (en) 2013-01-31

Similar Documents

Publication Publication Date Title
AR066584A1 (es) Formulaciones farmaceuticas que contienen nicotina. uso.
AR060932A1 (es) Producto y su uso y elaboracion
AR125327A2 (es) Composiciones de neisseria meningitidis y métodos de las mismas
CY1123334T1 (el) Σκευασματα φιναστεριδης για αποδεσμευση φαρμακου στα μαλλια και στο τριχωτο της κεφαλης
AR095456A1 (es) Composiciones de dos componentes que contienen complejos de halogenuro de cinc y aminoácido y cisteína
AR059006A1 (es) Composiciones de un anticonvulsivo y metodos para usarlas para revertir el aumento de peso
PE20110543A1 (es) Formulacion solida oral que comprende linaclotida, cation de calcio y leucina
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
CO6290624A2 (es) Composición oral que contiene amino ácidos, fluoruro y un tampón, y método de preparación de la misma
RU2009146580A (ru) Состав, содержащий никотин, с покрытием для перорального применения с буферными свойствами, приданными аминокислотой
EA201100896A1 (ru) Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение
PE20140960A1 (es) Formulaciones que comprenden un inhibidor de dpp4
PE20110023A1 (es) Composiciones inmunogenicas de antigenos de staphylococcus aureus
PH12015500301B1 (en) A novel formulation of diclofenac
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
BR112014017756A8 (pt) Sistema de administração transmucosa para um medicamento
CL2011001178A1 (es) Uso de (r)-7-cloro-niquinuclidin-3-1l)senzo[b]tiofen0-2-carboxamida o una sal de la misma o una composicion farmaceutica que la comprende para preparar un medicamento util para mejorar la cognicion en un paciente que sufre de alzheimer o esquizofrenia.
CY1120852T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ιβουπροφαινη, τραμαδολη και ενα βασικο αμινοξυ, μεθοδος παρασκευης αυτης και χρηση της ιδιας
AR077384A1 (es) Una formulacion farmaceutica inyectable de melfalano.
EA201170512A1 (ru) Композиция для перорального введения
BR122021012549B8 (pt) Composição de dissolução oral de melatonina com agente acidificante que torna melatonina solúvel em saliva
ECSP10010576A (es) Formulaciones orales e inyectables de compuestos de tetraciclina
CL2009001137A1 (es) Compuestos derivados de cicloheptanocarboniloxi-1-azonia-biciclo[2.2.2]-octano, moduladores de receptores muscarinicos; composiciones farmaceuticas; proceso de preparacion de dicha composicion; y uso en el tratamiento de una enfermedad pulmonar obstructiva cronica.
EA201591188A1 (ru) Доставка глатирамера ацетата через слизистую оболочку
CY1113279T1 (el) Φαρμακευτικη συνθεση 271

Legal Events

Date Code Title Description
FA Abandonment or withdrawal